|
LONP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.816300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.049800E-04 |
| Normal-vs-Stage2 |
3.397200E-01 |
| Normal-vs-Stage3 |
5.198800E-01 |
| Normal-vs-Stage4 |
3.56890000000609E-05 |
| Stage1-vs-Stage2 |
4.220000E-01 |
| Stage1-vs-Stage3 |
1.200000E-01 |
| Stage1-vs-Stage4 |
9.611700E-02 |
| Stage2-vs-Stage3 |
2.950600E-01 |
| Stage2-vs-Stage4 |
7.452300E-02 |
| Stage3-vs-Stage4 |
3.227600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.551970E-02 |
| Normal-vs-AfricanAmerican |
1.404400E-02 |
| Normal-vs-Asian |
3.576800E-01 |
| Caucasian-vs-AfricanAmerican |
6.300000E-01 |
| Caucasian-vs-Asian |
8.323400E-01 |
| AfricanAmerican-vs-Asian |
9.245200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.380600E-04 |
| Normal-vs-Female |
9.768200E-01 |
| Male-vs-Female |
1.678110E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.980320E-03 |
| Normal-vs-Extreme_Weight |
1.540390E-02 |
| Normal-vs-Obese |
2.343800E-01 |
| Normal-vs-Extreme_Obese |
5.166600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.606000E-01 |
| Normal_Weight-vs-Obese |
8.102500E-02 |
| Normal_Weight-vs-Extreme_Obese |
3.772200E-01 |
| Extreme_Weight-vs-Obese |
1.955420E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.385600E-01 |
| Obese-vs-Extreme_Obese |
8.917000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.167800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.553000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.217800E-04 |
| Normal-vs-Age(81-100Yrs) |
4.268500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.431800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.317400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.435600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.360980E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.072000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.578600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.67373999999665E-05 |
| Normal-VS-Type2 PRCC |
9.501000E-01 |
| Normal-VS-KIRP CIMP |
6.517800E-01 |
| Normal-VS-Unclassified PRCC |
7.363000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.546100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.609800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.522000E-03 |
| Type2 PRCC-VS-KIRP CIMP |
8.152000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.666800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.873400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.364000E-01 |
| Normal-vs-N1 |
1.386210E-01 |
| Normal-vs-N2 |
6.163800E-03 |
| N0-vs-N1 |
6.738400E-01 |
| N0-vs-N2 |
1.852580E-01 |
| N1-vs-N2 |
3.464600E-01 |
|
|
